Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load

被引:29
作者
Gao, P [1 ]
Witt, MJ [1 ]
Haskell, RJ [1 ]
Zamora, KM [1 ]
Shifflett, JR [1 ]
机构
[1] Pfizer Inc, Michigan Pharmaceut Sci, Kalamazoo, MI 49007 USA
关键词
experimental mixture design; emulsion; self-emulsifying drug delivery system; surface response methodology; particle size analysis;
D O I
10.1081/PDT-200031441
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Response surface methodology (RSM) was applied to optimize the self-emulsifying drug delivery system (SEDDS) containing 25% (w/w) Drug A, a model drug with a high lipophilicity and low water solubility. The key objective of this study was to identify an optimal SEDDS formulation that: 1) possesses a minimum concentration of the surfactant and a maximum concentration of lipid and 2) generates a fine emulsion and eliminates large size droplets (greater than or equal to1 mum) upon dilution with an aqueous medium. Three ingredient variables [PEG 400, Cremophor EL, and a mixture of glycerol dioleate (GDO), and glycerol monooleate (GMO)] were included in the experimental design, while keeping the other ingredients at a fixed level (25% Drug A, 6% ethanol, 3% propylene glycol, 4% water, and 2% tromethamine) in the SEDDS formulation. Dispersion performance of these formulations upon dilution with a simulated gastrointestinal fluid was measured, and the population of the large droplets was used as the primary response for statistical modeling. The results of this mixture study revealed significant interactions among the three ingredients, and their individual levels in the formulation collectively dictated the dispersion performance. The fitted response surface model predicted an optimal region of the SEDDS formulation compositions that generate fine emulsions and essentially eliminates large droplets upon dilution. The predicted optimal 25% Drug A-SEDDS formulations with the levels of Cremophor EL ranging from 40-44%, GDO/GMO ranging from 10-13%, and PEG 400 ranging from 2.7-9.0% were selected and prepared. The dispersion experiment results confirmed the prediction of this model and identified potential optimal formulations for further development. This work demonstrates that RSM is an efficient approach for optimization of the SEDDS formulation.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 20 条
[1]
Cataplasm-based controlled drug delivery: Development and optimization of a novel formulation [J].
Agarwal, V ;
Singh, SK ;
Reddy, IK ;
Durrani, MJ ;
Khan, MA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (05) :659-665
[2]
Experimental design for a pharmaceutical formulation: optimisation and robustness [J].
Campisi, B ;
Chicco, D ;
Vojnovic, D ;
Phan-Tan-Luu, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (1-2) :57-65
[3]
MIXTURE EXPERIMENTAL-DESIGN IN THE DEVELOPMENT OF A MUCOADHESIVE GEL FORMULATION [J].
CHU, JS ;
AMIDON, GL ;
WEINER, ND ;
GOLDBERG, AH .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1401-1407
[4]
Cornell JA, 2002, EXPT MIXTURES DESIGN
[5]
A FIBEROPTIC PROBE FOR PARTICLE SIZING IN CONCENTRATED SUSPENSIONS [J].
DHADWAL, HS ;
ANSARI, RR ;
MEYER, WV .
REVIEW OF SCIENTIFIC INSTRUMENTS, 1991, 62 (12) :2963-2968
[6]
Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures [J].
Driscoll, DF ;
Bacon, MN ;
Bistrian, BR .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2000, 24 (01) :15-22
[7]
Optimization of a reconstitutable suspension of rifampicin using 2(4) factorial design [J].
Elkheshen, SA ;
Badawi, SS ;
Badawi, AA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (07) :623-630
[8]
GAO P, UNPUB
[9]
A mixture experiment approach for controlling the dissolution rate of a sustained-release tablet [J].
Geoffroy, JM ;
Fredrickson, JK ;
Shelton, JT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (09) :799-806
[10]
Jumaa M., 1999, PHARM ACTA HELV, V73, P293, DOI DOI 10.1016/S0031-6865(99)00003-5